CANCER VACCINES

The present disclosure provides (a) isolated immunogenic TAA polypeptides (i.e., an immunogenic MUC1 polypeptides, an immunogenic MSLN polypeptides, and an immunogenic TERT polypeptides), (b) isolated nucleic acid molecules encoding one or more immunogenic TAA polypeptides, (c) vaccine compositions...

Full description

Saved in:
Bibliographic Details
Main Authors FALCONER, DEREK JOHN, JOOSS, KARIN UTE, MARTINIC, MARIANNE MARCELA ANDREA, WILLS, KENNETH NELSON, CHO, HELEN KIM, COCKLE, PAUL JASON, BINDER, JOSEPH JOHN, GURU, SIRADANAHALLI
Format Patent
LanguageEnglish
Polish
Published 16.11.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract The present disclosure provides (a) isolated immunogenic TAA polypeptides (i.e., an immunogenic MUC1 polypeptides, an immunogenic MSLN polypeptides, and an immunogenic TERT polypeptides), (b) isolated nucleic acid molecules encoding one or more immunogenic TAA polypeptides, (c) vaccine compositions comprising an immunogenic TAA polypeptide or an isolated nucleic acid molecule encoding an immunogenic TAA polypeptide, and (d) methods relating to uses of the polypeptides, nucleic acid molecules, and compositions.
AbstractList The present disclosure provides (a) isolated immunogenic TAA polypeptides (i.e., an immunogenic MUC1 polypeptides, an immunogenic MSLN polypeptides, and an immunogenic TERT polypeptides), (b) isolated nucleic acid molecules encoding one or more immunogenic TAA polypeptides, (c) vaccine compositions comprising an immunogenic TAA polypeptide or an isolated nucleic acid molecule encoding an immunogenic TAA polypeptide, and (d) methods relating to uses of the polypeptides, nucleic acid molecules, and compositions.
Author FALCONER, DEREK JOHN
GURU, SIRADANAHALLI
MARTINIC, MARIANNE MARCELA ANDREA
WILLS, KENNETH NELSON
BINDER, JOSEPH JOHN
COCKLE, PAUL JASON
CHO, HELEN KIM
JOOSS, KARIN UTE
Author_xml – fullname: FALCONER, DEREK JOHN
– fullname: JOOSS, KARIN UTE
– fullname: MARTINIC, MARIANNE MARCELA ANDREA
– fullname: WILLS, KENNETH NELSON
– fullname: CHO, HELEN KIM
– fullname: COCKLE, PAUL JASON
– fullname: BINDER, JOSEPH JOHN
– fullname: GURU, SIRADANAHALLI
BookMark eNrjYmDJy89L5WTgd3b0c3YNUghzdHb29HMN5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8QE-xiYGpkaGRiEhxsbEqAEAnRofOA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Szczepionki przeciwnowotworowe
ExternalDocumentID PL3405212TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_PL3405212TT33
IEDL.DBID EVB
IngestDate Fri Aug 30 05:41:23 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Polish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_PL3405212TT33
Notes Application Number: PL20170702951T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201116&DB=EPODOC&CC=PL&NR=3405212T3
ParticipantIDs epo_espacenet_PL3405212TT3
PublicationCentury 2000
PublicationDate 20201116
PublicationDateYYYYMMDD 2020-11-16
PublicationDate_xml – month: 11
  year: 2020
  text: 20201116
  day: 16
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies Pfizer Inc
RelatedCompanies_xml – name: Pfizer Inc
Score 3.3050978
Snippet The present disclosure provides (a) isolated immunogenic TAA polypeptides (i.e., an immunogenic MUC1 polypeptides, an immunogenic MSLN polypeptides, and an...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title CANCER VACCINES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201116&DB=EPODOC&locale=&CC=PL&NR=3405212T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUlNNjS3MLPQNUk1MdY1MTOy1LVISU7TNU5LMTJNBIqZgE9i8vUz8wg18YowjWBiyITthQGfE1oOPhwRmKOSgfm9BFxeFyAGsVzAayuL9ZMygUL59m4hti5q0N4xqDYzNFNzcbJ1DfB38XdWc3a2DfBR8wsCFtbgXaohxswMrKBWNOiYfdcwJ9CmlALkGsVNkIEtAGhYXokQA1NBjjADpzPs4jVhBg5f6Hw3kAnNesUiDPzOoGtkghTCHJ2dQTdliDIourmGOHvoAk2Oh_siPsAH5oYQY2MxBhZg7z5VgkEhNSkp0TAtNcXCNNXSxNI4LckoydLU2DzZAthOMbRItZBkkMJtjhQ-SWkGLlCIgDbOGZrJMLCUFJWmygJr0JIkObDfAezqcm8
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUlNNjS3MLPQNUk1MdY1MTOy1LVISU7TNU5LMTJNBIqZgE9i8vUz8wg18YowjWBiyITthQGfE1oOPhwRmKOSgfm9BFxeFyAGsVzAayuL9ZMygUL59m4hti5q0N4xqDYzNFNzcbJ1DfB38XdWc3a2DfBR8wsCFtbgXaohxswMrObAHiG4pxTmBNqUUoBco7gJMrAFAA3LKxFiYCrIEWbgdIZdvCbMwOELne8GMqFZr1iEgd8ZdI1MkEKYo7Mz6KYMUQZFN9cQZw9doMnxcF_EB_jA3BBibCzGwALs3adKMCikJiUlGqalpliYplqaWBqnJRklWZoamydbANsphhapFpIMUrjNkcInKc_A6RHi6xPv4-nnLc3ABQod0CY6QzMZBpaSotJUWWBtWpIkBw4HAGt4dVk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CANCER+VACCINES&rft.inventor=FALCONER%2C+DEREK+JOHN&rft.inventor=JOOSS%2C+KARIN+UTE&rft.inventor=MARTINIC%2C+MARIANNE+MARCELA+ANDREA&rft.inventor=WILLS%2C+KENNETH+NELSON&rft.inventor=CHO%2C+HELEN+KIM&rft.inventor=COCKLE%2C+PAUL+JASON&rft.inventor=BINDER%2C+JOSEPH+JOHN&rft.inventor=GURU%2C+SIRADANAHALLI&rft.date=2020-11-16&rft.externalDBID=T3&rft.externalDocID=PL3405212TT3